PDS Biotechnology Corp Operating Lease, Payments
PDS Biotechnology Corp (PDSB) reported Operating Lease, Payments of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2025-03-27
- PDS Biotechnology Corp operating lease, payments for the quarter ending 2024-12-31 was $0.00.
- PDS Biotechnology Corp operating lease, payments for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp operating lease, payments for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp operating lease, payments for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- PDS Biotechnology Corp operating lease, payments for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- PDS Biotechnology Corp operating lease, payments for fiscal 2023 was $239.47K, a 18.82% decline from fiscal 2022.
- PDS Biotechnology Corp operating lease, payments for fiscal 2022 was $294.99K, a 72.67% increase from fiscal 2021.
- PDS Biotechnology Corp operating lease, payments for fiscal 2021 was $170.84K, a 74.09% increase from fiscal 2020.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 3 month as first filed | Operating Lease, Payments 6 month | Operating Lease, Payments 6 month as first filed | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $0.00 derived: sum of 2 quarters · filed 2025-03-27 | $0.00 derived: sum of 3 quarters · filed 2025-03-27 | $0.00 10-K · filed 2025-03-27 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $0.00 derived: sum of 2 quarters · filed 2024-11-14 | $0.00 10-Q · filed 2024-11-14 | $0.00 derived: sum of 4 quarters · filed 2025-03-27 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $0.00 10-Q · filed 2024-08-13 | $0.00 derived: sum of 3 quarters · filed 2025-03-27 | $60.33K derived: sum of 4 quarters · filed 2025-03-27 | ||
| 2024-03-31 | $0.00 10-Q · filed 2024-05-15 | $0.00 derived: sum of 2 quarters · filed 2025-03-27 | $60.33K derived: sum of 3 quarters · filed 2025-03-27 | $150.37K derived: sum of 4 quarters · filed 2025-03-27 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $60.33K derived: sum of 2 quarters · filed 2025-03-27 | $150.37K derived: sum of 3 quarters · filed 2025-03-27 | $239.47K 10-K · filed 2025-03-27 | ||
| 2023-09-30 | $60.33K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $150.37K derived: sum of 2 quarters · filed 2024-11-14 | $239.47K 10-Q · filed 2024-11-14 | $328.57K derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | $90.03K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $179.14K 10-Q · filed 2024-08-13 | $268.24K derived: sum of 3 quarters · filed 2024-08-13 | $357.34K derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $89.10K 10-Q · filed 2024-05-15 | $178.20K derived: sum of 2 quarters · filed 2024-05-15 | $267.31K derived: sum of 3 quarters · filed 2024-05-15 | $341.04K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $89.10K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $178.20K derived: sum of 2 quarters · filed 2024-03-28 | $251.94K derived: sum of 3 quarters · filed 2024-03-28 | $294.99K 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $89.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $162.84K derived: sum of 2 quarters · filed 2023-11-14 | $205.88K 10-Q · filed 2023-11-14 | $248.92K derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $73.74K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $116.78K 10-Q · filed 2023-08-14 | $159.82K derived: sum of 3 quarters · filed 2023-08-14 | $203.51K derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $43.05K 10-Q · filed 2023-05-15 | $43.04K 10-Q · filed 2022-05-11 | $86.08K derived: sum of 2 quarters · filed 2023-05-15 | $129.77K derived: sum of 3 quarters · filed 2023-05-15 | $171.83K derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $43.03K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-28 | $86.72K derived: sum of 2 quarters · filed 2023-03-28 | $128.78K derived: sum of 3 quarters · filed 2023-03-28 | $170.84K 10-K · filed 2023-03-28 | ||
| 2021-09-30 | $43.69K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $85.75K derived: sum of 2 quarters · filed 2022-11-14 | $127.80K 10-Q · filed 2022-11-14 | $163.34K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $42.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $84.11K 10-Q · filed 2022-08-08 | $119.65K derived: sum of 3 quarters · filed 2022-08-08 | $166.60K derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-03-31 | $42.06K 10-Q · filed 2022-05-11 | $42.06K 10-Q · filed 2021-05-13 | $77.59K derived: sum of 2 quarters · filed 2022-05-11 | $124.54K derived: sum of 3 quarters · filed 2022-05-11 | $140.19K derived: sum of 4 quarters · filed 2022-05-11 | |
| 2020-12-31 | $35.54K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $82.48K derived: sum of 2 quarters · filed 2022-03-31 | $98.13K derived: sum of 3 quarters · filed 2022-03-31 | $98.13K 10-K · filed 2022-03-31 | ||
| 2020-09-30 | $46.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $62.60K derived: sum of 2 quarters · filed 2021-11-10 | $62.60K 10-Q · filed 2021-11-10 | $62.60K derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $15.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $15.65K 10-Q · filed 2021-08-12 | $15.65K derived: sum of 3 quarters · filed 2021-08-12 | $15.65K derived: sum of 4 quarters · filed 2021-08-12 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-13 | $0.00 derived: sum of 2 quarters · filed 2021-05-13 | $0.00 derived: sum of 3 quarters · filed 2021-05-13 | -$49.32K derived: sum of 4 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $0.00 derived: sum of 2 quarters · filed 2021-03-18 | -$49.32K derived: sum of 3 quarters · filed 2021-03-18 | $0.00 10-K · filed 2021-03-18 | ||
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | -$49.32K derived: sum of 2 quarters · filed 2020-11-13 | $0.00 10-Q · filed 2020-11-13 | |||
| 2019-06-30 | -$49.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 | $172.63K 10-Q · filed 2019-08-01 | |||
| 2019-03-31 | $49.32K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |